The notion of tumour marker and its interpretation have gone through several stages of development. The research of marker substances date back several decades. They include the discovery of the individual markers, the development of methods of detection, and the different stages of their clinical use. The widescope clinical use of tumour markers have greatly contributed to the successful detection of malignant tumours and to the higher effectiveness of their therapy. In a reasonable combination, most of the tumour markers are primarily suitable for the monitoring and follow up of tumourous processes already diagnosed. Since the clinical use of tumour markers in Hungary is disastrous compared to the practice of countries belonging to the European Community, authors propose drastic changes in order to ensure up-to-date oncological care in Hungary. When making up our underdevelopment according to international standards it would be essential to develop a network of regional centres with up-to-date laboratory background of high capacity. The high capacity tumour marker laboratory of the National Institute of Oncology could serve as a model. It works with external and internal quality control and is suitable for further developments and scientific analysis of the laboratory data.
|Translated title of the contribution||Planning and improving of tumour marker examinations in Hungary|
|Number of pages||4|
|Journal||Lege Artis Medicinae|
|Publication status||Published - Apr 14 1999|
ASJC Scopus subject areas